To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Kamada's anti-rabies therapy

Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) said FDA approved Kedrab

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE